AI assistant
Sending…
GT Biopharma, Inc. — Director's Dealing 2021
Oct 7, 2021
35496_dirs_2021-10-07_bfab82dc-a83d-4086-9513-ff456d3599ed.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: GT Biopharma, Inc. (GTBP)
CIK: 0000109657
Period of Report: 2020-11-11
Reporting Person: Wendel Bruce (N/A)
More from GT Biopharma, Inc.
Regulatory Filings
2026
May 22
Interim / Quarterly Report
2026
May 15
Regulatory Filings
2026
May 14
Regulatory Filings
2026
May 13
Regulatory Filings
2026
Apr 30
Regulatory Filings
2026
Apr 7
Interim / Quarterly Report
2026
Mar 6
Interim / Quarterly Report
2026
Mar 6
Annual Report
2026
Mar 2
Regulatory Filings
2026
Mar 2